<DOC>
	<DOCNO>NCT03076775</DOCNO>
	<brief_summary>Annually U.S 300,000 neonate bear late preterm , define 34 week 0 day - 36 week 6 day . The Antenatal Late Preterm Steroids ( ALPS ) Trial demonstrate maternal treatment betamethasone late preterm period significantly reduce neonatal respiratory complication , also increase neonatal hypoglycemia , compare placebo . This research study attempt answer follow primary question : Does management protocol aim maintain maternal euglycemia ALPS decrease neonatal hypoglycemia , compare usual antepartum care ? The research study also collect information relationship timing delivery ALPS neonatal hypoglycemia .</brief_summary>
	<brief_title>Euglycemia After Antenatal Late Preterm Steroids</brief_title>
	<detailed_description>Euglycemia Antenatal Late Preterm Steroids , E-ALPS Study : There fundamental gap understand adverse metabolic effect antenatal late preterm steroid ( ALPS ) . In 2016 , important randomize clinical trial 2827 late preterm pregnancy show antenatal betamethasone ( BMZ ) significantly reduce neonatal respiratory complication compare placebo . However , neonate expose BMZ also likely hypoglycemia birth . This unexpected adverse outcome raise concern among obstetrician neonatologists remain important knowledge gap fill . The rationale propose research steroid-induced maternal hyperglycemia lead transient fetal hyperinsulinemia , cause hypoglycemia neonate deliver time-period . Thus , neonatal hypoglycemia observe exposure BMZ utero prevent achieve maternal euglycemia prior delivery . This protocol describe randomize clinical trial evaluate whether screen treatment steroid-induced hyperglycemia non-diabetic woman treat BMZ late preterm period decrease rate neonatal hypoglycemia , thus improve short-term neonatal outcome .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>1 . Singleton gestation know major fetal anomaly 2 . Gestational age randomization 34 week 0 day 36 week 5 day 3 . Receiving antenatal betamethasone due high probability delivery late preterm period 1 . Pregestational gestational diabetes mellitus 2 . Maternal contraindication insulin 3 . Planned outpatient treatment antenatal betamethasone 4 . Participation clinical trial could affect primary outcome participation trial previous pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Betamethasone</keyword>
	<keyword>Late preterm</keyword>
	<keyword>Steroids</keyword>
</DOC>